Publications by authors named "Rosalba Miceli"

100Publications

Commentary: SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China.

Front Oncol 2020 10;10:1223. Epub 2020 Jul 10.

Clinical Epidemiology and Trial Organization Unit, Department of Applied Research and Technological Development, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

View Article and Find Full Text PDF
July 2020

Reply to E. Hindié.

J Clin Oncol 2020 Sep 23;38(27):3238-3240. Epub 2020 Jul 23.

Andrea Maurichi, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Rosalba Miceli, PhD, Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Hanna Eriksson, MD, PhD, Department of Oncology, Theme Cancer, Karolinska University Hospital, and Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden; Julia Newton-Bishop, MD, FRCP; Jérémie Nsengimana, PhD; and May Chan, PGD, Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, United Kingdom; Andrew J. Hayes, MA, MBBS, MD, PhD and Kara Heelan, MB, BCH, BAO, MRCPI, MD, Sarcoma and Melanoma Units and Skin Unit, The Royal Marsden National Health Service (NHS) Foundation Trust, London, United Kingdom; David Adams, PhD, Experimental Cancer Genetics, Wellcome Trust Sanger Institute, Hinxton, United Kingdom; Roberto Patuzzo, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Francesco Barretta, MS, PhD, Medical Statistics, Biometry and Bioinformatics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Gianfranco Gallino, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Catherine Harwood, MA, MD, PhD, FRCP and Daniele Bergamaschi, PhD, Queen Mary University of London, London, United Kingdom; Dorothy Bennett, FMedSci, PhD, Molecular and Clinical Sciences Research Institute, St George's, University of London, London, United Kingdom; Konstantinos Lasithiotakis, MD, PhD, York Teaching Hospital NHS Foundation Trust, York, United Kingdom and Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Paola Ghiorzo, MD, PhD and Bruna Dalmasso, MD, University Hospital of Genoa, Genoa, Italy; Ausilia Manganoni, MD and Francesca Consoli, MD, University Hospital of Brescia, Brescia, Italy; Ilaria Mattavelli, MD; Consuelo Barbieri, MD; and Andrea Leva, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Umberto Cortinovis, MD, Plastic and Reconstructive Surgical Unit, Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Vittoria Espeli, MD and Cristina Mangas, MD, PhD, Istituto Oncologico Svizzera Italiana, Ospedale Regionale Bellinzona e Valli, Bellinzona, Switzerland; Pietro Quaglino, MD; Simone Ribero, MD, PhD; and Paolo Broganelli, MD, University Hospital of Turin, Turin, Italy; Giovanni Pellacani, MD, University Hospital of Modena, Modena, Italy; Caterina Longo, MD, Arcispedale S. Maria Nuova, Reggio Emilia, Italy; Corrado Del Forno, MD, University Hospital of Pavia, Pavia, Italy; Lorenzo Borgognoni, MD and Serena Sestini, MD, Ospedale S. Maria Annunziata, Tuscan Cancer Institute, Florence, Italy; Nicola Pimpinelli, MD, PhD and Sara Fortunato, MD, Division of Dermatology, University of Florence, Florence, Italy; Alessandra Chiarugi, MD and Paolo Nardini, MD, Institute for Cancer Research and Prevention, Florence, Italy; Elena Morittu, PhD and Antonio Florita, PhD, Scientific Director's Office, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Mara Cossa, MD, PhD; Barbara Valeri, MD; Massimo Milione, MD, PhD; and Giancarlo Pruneri, MD, Department of Pathology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; Odysseas Zoras, MD, PhD, University Hospital of Heraklion, Heraklion, Greece; Andrea Anichini, PhD and Roberta Mortarini, PhD, Immunobiology of Human Cancers Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy; and Mario Santinami, MD, Melanoma and Sarcoma Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

View Article and Find Full Text PDF
September 2020

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019.

Eur J Cancer 2020 08 4;135:62-65. Epub 2020 Jun 4.

Medica Scientia Innovation Research (MedSIR), Ridgewood, NJ, USA and Barcelona, Spain; IOB Institute of Oncology, Quironsalud Group, Madrid and Barcelona, Spain; Vall D´Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address:

View Article and Find Full Text PDF
August 2020

Outcome of iliocaval resection and reconstruction for retroperitoneal sarcoma.

J Vasc Surg Venous Lymphat Disord 2019 07 18;7(4):547-556. Epub 2019 Feb 18.

Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

View Article and Find Full Text PDF
July 2019

Prognostic factors in recurrent or metastatic squamous cell carcinoma of the head and neck.

Head Neck 2019 06 16;41(6):1895-1902. Epub 2019 Jan 16.

Head & Neck Cancer Medical Oncology Department, Fondazione IRCCS "Istituto Nazionale dei Tumori" and University of Milan, Milan, Italy.

View Article and Find Full Text PDF
June 2019

In Reply to Fakhry et al.

Int J Radiat Oncol Biol Phys 2018 11;102(3):670-671

Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Department of Oncology and Hemato-oncology, Milan, Italy.

View Article and Find Full Text PDF
November 2018

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer.

BMC Cancer 2018 Sep 18;18(1):899. Epub 2018 Sep 18.

Department of Research, Tumor Genomics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Venezian 1, 20133, Milan, Italy.

View Article and Find Full Text PDF
September 2018

Urn models for response-adaptive randomized designs: a simulation study based on a non-adaptive randomized trial.

J Biopharm Stat 2018 22;28(6):1203-1215. Epub 2018 Mar 22.

b Laboratorio di Statistica Medica, Biometria, ed Epidemiologia "G. A. Maccacaro", Dipartimento di Scienze Cliniche e di Comunità , Università degli Studi di Milano , Milano , Italy.

View Article and Find Full Text PDF
October 2019

Extracellular matrix proteins as diagnostic markers of breast carcinoma.

J Cell Physiol 2018 08 9;233(8):6280-6290. Epub 2018 Mar 9.

Molecular Targeting Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article and Find Full Text PDF
August 2018

Prognostic models for RPS patients-Attempting to predict patient outcomes.

J Surg Oncol 2018 Jan 19;117(1):69-78. Epub 2017 Dec 19.

Department of Surgery, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

View Article and Find Full Text PDF
January 2018

Sarcoma nomograms: a light over the darkness.

Oncoscience 2017 Mar 16;4(3-4):15-16. Epub 2017 Mar 16.

Department of Surgery, Sarcoma Service, Fondazione IRCCS Istituto Nazionale dei Tumori, 20133 Milan, Italy.

View Article and Find Full Text PDF
March 2017

Soft tissue sarcoma nomograms and their incorporation into practice.

Cancer 2017 Aug 10;123(15):2802-2820. Epub 2017 May 10.

Department of Surgery, Fondazione IRCCS Istituto Nazionale Tumori, Milan, Italy.

View Article and Find Full Text PDF
August 2017

Impact of home enteral nutrition in malnourished patients with upper gastrointestinal cancer: A multicentre randomised clinical trial.

Eur J Cancer 2016 09 5;64:107-12. Epub 2016 Jul 5.

Unit of Medical Statistics, Biometry, Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article and Find Full Text PDF
September 2016

Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.

Neuro Oncol 2016 10 18;18(10):1451-60. Epub 2016 May 18.

Department of Pediatrics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (M.M., L.B., V.B., E.S.); Department of Medical Statistics, Biometry, and Bioinformatics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (R.M.); Pediatric Radiotherapy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (L.G., E.P., B.D.); Department of Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy (G.C.); Department of Radiological, Oncological, and Anatomo-Pathological Sciences, Sapienza University, Rome, Italy (F.G., M.A.); Department of Neurology and Psychiatry, Sapienza University, Rome, Italy (F.R.B.); IRCCS Neuromed, Pozzilli, Italy (F.G.); Laboratory of Genetics, Pathology Unit, S. Anna General Hospital, Como, Italy (P.M.); Neurosurgery Department, IRCCS Istituto Neurologico Carlo Besta, Milan, Italy (P.F., L.V.); Pathology Unit, IRCCS Istituto Neurologico Carlo Besta, Milan, Italy (B.P.); Department of Pediatric Onco-Hematology, Regina Margherita Children's Hospital, Torino, Italy (D.B.); Department of Neurosurgery, Regina Margherita Children's Hospital, Torino, Italy (P.P.); Radiotherapy Unit, Regina Margherita Children's Hospital, Torino, Italy (A.M.); Istituto Giannina Gaslini, Genova, Italy (M.L.G., A.C.); Department of Neuro-oncology, Ospedale Pediatrico Meyer, Firenze, Italy (I.S.); Neurosurgery Unit, Ospedale Pediatrico Meyer, Firenze, Italy (L.G.); Pediatric Oncology Unit, Padova University, Padova, Italy (E.V.); Radiotherapy Department, IOV-IRCCS, Padova, Italy (G.S.); Department of Radiation Oncology, Careggy Hospital, Firenze, Italy (S.S.); Pathology Unit, Careggy Hospital, Firenze, Italy (A.B.); Department of Pediatric Radiotherapy, CRO, Aviano, Italy (M.M.); Department of Pediatric Oncology, Ospedale Santobono-Pausillipon, Napoli, Italy (L.Q.); Neurosurgery Unit, Ospedale Santobono-Pausillipon, Napoli, Italy (G.C.); Department of Radiation Oncology, IRCCS San Martino IST, National Cancer Research Institute, Ge

View Article and Find Full Text PDF
October 2016

Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS): A Report on 1007 Patients From the Multi-institutional Collaborative RPS Working Group.

Ann Surg 2016 May;263(5):1002-9

*Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy †Department of Surgery, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom ‡Department of Biostatistics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy §Department of Surgery, Institute Gustave Roussy, Villejuif, France ¶Department of Surgical Oncology, Mount Sinai Hospital and Princess Margaret Cancer Centre, and Department of Surgery, University of Toronto, Toronto, Ontario, Canada ||Division of Surgical Oncology & Thoracic Surgery, Mannheim University Hospital, Mannheim, Germany **Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands ††Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland ‡‡Department of Surgery, Division of Surgical Oncology, Brigham and Women's Hospital and Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA §§Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands ¶¶Department of Cancer Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy ||||Department of Surgery, Division of Surgical Oncology, Ohio State University Medical Center, Columbus, OH.

View Article and Find Full Text PDF
May 2016

The Changing Landscape of Intermediate- and Poor-Risk Germ Cell Tumors: Do We Need to Reclassify Patients With Metastatic Germ Cell Tumors?

Clin Genitourin Cancer 2016 Feb 6;14(1):1-4. Epub 2015 Aug 6.

Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article and Find Full Text PDF
February 2016

KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based study.

Am J Surg Pathol 2015 Jul;39(7):922-30

*Department of Pathology and Molecular Genetics, Treviso General Hospital, Treviso †Experimental Oncology I, CRO Aviano National Cancer Institute, Aviano ‡Clinical Epidemiology and Trial Organization, Fondazione IRCCS Istituto Nazionale Tumori **Department of Pathology, IRCCS San Raffaele Hospital, Milano §Department of Pathology, Firenze University School of Medicine, Firenze ∥Department of Pathology, University of Marche, Ancona School of Medicine, Ancona ¶Department of Pathology, General Hospital, Bolzano #Department of Pathology, Macchi Foundation, Varese ††Department of Pathology, General Hospital, Bergamo ‡‡Department of Pathology, Perugia University, School of Medicine, Perugia §§Novartis Farma, Origgio Departments of ∥∥Surgery ¶¶Cancer Medicine, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.

View Article and Find Full Text PDF
July 2015

Myogenic differentiation and histologic grading are major prognostic determinants in retroperitoneal liposarcoma.

Am J Surg Pathol 2015 Mar;39(3):383-93

Departments of *Surgery †Pathology ‡Biostatistics §Cancer Medicine ∥Radiology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan ¶Department of Pathology, Azienda ULSS 9, Treviso, Italy.

View Article and Find Full Text PDF
March 2015

Etoposide, Methotrexate, and Dactinomycin Alternating With Cyclophosphamide and Vincristine (EMACO) for Male Patients With HCG-expressing, Chemoresistant Germ Cell Tumors.

Am J Clin Oncol 2017 02;40(1):60-65

*Department of Medical Oncology †Clinical Epidemiology and Trials Organization Unit ‡Department of Surgery, Urology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori §Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.

View Article and Find Full Text PDF
February 2017

Prediction of survival in patients with thin melanoma: results from a multi-institution study.

J Clin Oncol 2014 Aug 7;32(23):2479-85. Epub 2014 Jul 7.

Andrea Maurichi, Rosalba Miceli, Tiziana Camerini, Luigi Mariani, Roberto Patuzzo, Roberta Ruggeri, Gianfranco Gallino, Elena Tolomio, Gabrina Tragni, Barbara Valeri, Andrea Anichini, Roberta Mortarini, Daniele Moglia, Mario Santinami, Fondazione Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS), Istituto Nazionale dei Tumori, Milan; Giovanni Pellacani, Sara Bassoli, Caterina Longo, University Hospital of Modena and Skin Cancer Unit IRCCS Arcispedale Santa Maria Nuova, Reggio Emilia; Pietro Quaglino, University Hospital of Turin, Turin; Nicola Pimpinelli, Lorenzo Borgognoni, University Hospital of Florence and Istituto Tumori Toscano, S. Maria Annunziata Hospital, Florence, Italy; Daniele Bergamaschi, Catherine Harwood, Queen Mary University of London, London, United Kingdom; and Odysseas Zoras, University Hospital of Heraklion, Crete, Greece.

View Article and Find Full Text PDF
August 2014

Adjuvant chemotherapy for gastric cancer: current evidence and future challenges.

World J Gastroenterol 2014 Apr;20(16):4516-25

Rosalba Miceli, Unit of Medical Statistics, Biometry and Bioinformatics, Fondazione IRCCS Istituto Nazionale Tumori, 20133 Milan, Italy.

View Article and Find Full Text PDF
April 2014

Cell proliferation of the primary tumor predicts ipsilateral axillary node disease in elderly breast cancer patients.

Int J Biol Markers 2013 Apr 23;28(1):24-31. Epub 2013 Apr 23.

Biomarkers Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

View Article and Find Full Text PDF
April 2013

Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?

Cancer 2012 Nov 19;118(21):5349-57. Epub 2012 Apr 19.

Department of Surgery-Sarcoma Service, Scientific Institutes for Recovery and Cure (IRCCS) Foundation, National Cancer Institute, Milan, Italy.

View Article and Find Full Text PDF
November 2012

Survival prediction for terminally ill cancer patients: revision of the palliative prognostic score with incorporation of delirium.

Oncologist 2011 31;16(12):1793-9. Epub 2011 Oct 31.

Biostatistics and Clinical Trials Unit, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola, Italy.

View Article and Find Full Text PDF
April 2012

Milan criteria in liver transplantation for hepatocellular carcinoma: an evidence-based analysis of 15 years of experience.

Liver Transpl 2011 Oct;17 Suppl 2:S44-57

Units of Gastrointestinal Surgery and Liver Transplantation, National Cancer Institute of Milan, Milan, Italy.

View Article and Find Full Text PDF
October 2011

Importance of early nutritional screening in patients with gastric cancer.

Br J Nutr 2011 Dec 17;106(12):1773-8. Epub 2011 Jun 17.

Clinical Nutrition Unit, National Cancer Institute, Via Venezian 1, 20133 Milan, Italy.

View Article and Find Full Text PDF
December 2011